Clinical Trial Update: Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

View source ↗

Summary

Clinical Trial Update for the MPN-IFN study shows that it remains active but not recruiting, studying autoantibodies against Type I Interferon in Ph-negative my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Myeloproliferative Disease, COVID - 19 | Status: ACTIVE_NOT_RECRUITING